Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Cellebrite DI (CLBT) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to 16.15%.

  • Cellebrite DI's EBIT Margin rose 17300.0% to 16.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.98%, marking a year-over-year decrease of 2100.0%. This contributed to the annual value of 13.98% for FY2025, which is 2100.0% down from last year.
  • As of Q4 2025, Cellebrite DI's EBIT Margin stood at 16.15%, which was up 17300.0% from 15.07% recorded in Q3 2025.
  • Over the past 5 years, Cellebrite DI's EBIT Margin peaked at 18.2% during Q3 2024, and registered a low of 8.95% during Q2 2022.
  • For the 5-year period, Cellebrite DI's EBIT Margin averaged around 9.43%, with its median value being 12.07% (2025).
  • As far as peak fluctuations go, Cellebrite DI's EBIT Margin tumbled by -228400bps in 2022, and later surged by 175300bps in 2023.
  • Cellebrite DI's EBIT Margin (Quarter) stood at 6.34% in 2021, then soared by 106bps to 13.07% in 2022, then rose by 23bps to 16.13% in 2023, then dropped by -11bps to 14.42% in 2024, then grew by 12bps to 16.15% in 2025.
  • Its EBIT Margin stands at 16.15% for Q4 2025, versus 15.07% for Q3 2025 and 12.73% for Q2 2025.